Obesity Science & Innovation Europe (OSI EU) — A Post-Conference Symposium to TIDES Europe

Name: Obesity Science & Innovation Europe (OSI EU)
Start: 2026-11-06
End: 2026-11-06
Location: nhow Amsterdam RAI

Join us in Amsterdam on 6 November 2026 for this exclusive one-day symposium dedicated to cutting-edge obesity therapeutics and metabolic health. Whether you're extending your stay following TIDES Europe or attending OSI EU as a standalone event, connect with leading experts to explore breakthrough advancements in GLP-1 therapies, RNA-based approaches, and next-generation obesity treatments. Discover how innovative therapeutic modalities are transforming approaches to one of healthcare's most pressing challenges.

6 November 2026
nhow Amsterdam RAI,
Amsterdam

Translating Obesity Innovation into European Impact: Bridging Breakthrough Science with Market Access and Commercial Success

Navigate the intersection of cutting-edge obesity therapeutics and European commercialization strategies

Dive into the latest clinical data on incretin-based therapies, RNA approaches, and next-generation treatments while gaining actionable insights on regulatory approval, pricing strategies, and reimbursement across diverse European markets. Connect with industry leaders and innovators driving the future of obesity care in Europe.

View Preliminary Agenda Apply to Speak

+

Attendees

+

Expert Speakers

+

Networking Hours

A Snapshot of the 2026 Agenda

GLP-1 & Next-Generation Multi-Agonist Therapies

Exploring clinical updates from leading GLP-1, dual, and triple agonist programs across peptide and small molecule modalities, including efficacy data and novel oral formulations addressing limitations of injectable therapies.

photo of cells including mitochondrial uncouplers and browning agents.

RNA-Based Approaches

Exploring RNA-based approaches for obesity, including siRNA-mediated inhibition of metabolic targets and non-coding RNA technologies with insights from Phase 1 clinical data.

scientist holding a petri dish working on obesity therapeutics

European Market Access & Commercialization Strategies

Navigating regulatory pathways, reimbursement frameworks, and market access challenges to successfully translate innovative obesity therapeutics into commercially viable solutions across diverse European healthcare systems.

Investment, Valuation & Strategic Partnerships

Examining valuation trends, licensing opportunities, and strategic collaborations shaping the obesity therapeutics landscape, with insights from leading investors, pharma BD&L teams, and emerging biotech innovators.

a measuring tape wrapped around some injectables for obesity therapeutics

Digital Health Integration

Integrating digital health solutions with obesity therapeutics to enhance patient engagement, treatment adherence, and real-world outcomes through connected technologies and data-driven personalization.

Dedicated Networking Hours

Connect with pharmaceutical executives, biotech innovators, clinical researchers, and investors during structured networking breaks designed to foster collaboration, exchange insights, and build strategic partnerships across the obesity innovation ecosystem.

View Preliminary Agenda

Frequently Asked Questions (FAQs)

What is Obesity Science & Innovation Europe (OSI EU)?

OSI EU is the annual European conference bringing together over 100 leading experts in obesity and metabolic health to shape the future of emerging obesity therapeutics. Attendees will have the opportunity to explore groundbreaking advancements in obesity research and metabolic health, diving deep into the latest innovations and clinical insights.

Discover cutting-edge developments in GLP-1 therapies, anti-obesity medications, RNA-based approaches, adipose-targeted treatments, and muscle preservation strategies. Gain valuable clinical perspectives on incretin-based therapies, mitochondrial uncouplers, and next-generation solutions revolutionizing the science of obesity and metabolism. Join us to stay at the forefront of this transformative field.

Register by 24 July to save £500